Method for decreasing low density lipoprotein
View Patent ↗The present invention relates to a method for decreasing elevated serum/plasma LDL-cholesterol levels or LDL-cholesterol levels and CRP levels in a mammal in need thereof. The methods comprises administering an effective amount of a tetracycline formulation. In one embodiment, the tetracycline formulation is a non-antibacterial tetracycline. In another embodiment, the tetracycline formulation is an antibacterial tetracycline at a sub-antibacterial amount.
1. A method for decreasing elevated serum/plasma low density lipoprotein-cholesterol levels in a mammal in need thereof, the method comprising administering to the mammal an effective amount of a tetracycline formulation.
2. A method according to claim 1 , wherein the tetracycline formulation comprises a non-antibacterial tetracycline.
3. A method according to claim 1 , wherein the tetracycline formulation comprises a antibacterial tetracycline at a sub-antibacterial amount.
4. A method according to claim 3 , wherein the antibacterial tetracycline is doxycycline.
5. A method according to claim 3 , wherein the antibacterial tetracycline is minocycline.
6. A method according to claim 2 , wherein the non-antibacterial tetracycline is CMT-3.
7. A method according to claim 2 , wherein the non-antibacterial tetracycline is CMT-308.
8. A method according to claim 2 , wherein the non-antibacterial tetracycline is CMT-8.
9. A method according to claim 2 , wherein the non-antibacterial tetracycline is CMT-10.
10. A method according to claim 2 , wherein the non-antibacterial tetracycline is CMT-1002.
11. A method for decreasing elevated serum/plasma low density lipoprotein-cholesterol levels and C-reactive protein levels in a mammal in need thereof, the method comprising administering to the mammal an effective amount of a tetracycline formulation.
12. A method according to claim 11 , wherein the tetracycline formulation comprises a non-antibacterial tetracycline.
13. A method according to claim 11 , wherein the tetracycline formulation comprises a antibacterial tetracycline at a sub-antibacterial amount.
14. A method according to claim 13 , wherein the antibacterial tetracycline is doxycycline.
15. A method according to claim 13 , wherein the antibacterial tetracycline is minocycline.
16. A method according to claim 12 , wherein the non-antibacterial tetracycline is CMT-3.
17. A method according to claim 12 , wherein the non-antibacterial tetracycline is CMT-308.
18. A method according to claim 12 , wherein the non-antibacterial tetracycline is CMT-8.
19. A method according to claim 12 , wherein the non-antibacterial tetracycline is CMT-10.
20. A method according to claim 12 , wherein the non-antibacterial tetracycline is CMT-1002.